Publikationen in Zusammenarbeit mit Forschern von Karolinska University Hospital (6)

2020

  1. Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 313-323

  2. One-year prognosis of patients with heart failure in Spain. ESC-EORP-HFA Heart Failure Long-Term Registry

    REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216

2019

  1. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397

2017

  1. Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy

    International Journal of Cardiology, Vol. 243, pp. 389-395

2011

  1. The European Cardiac Resynchronization Therapy Survey: Comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades

    European Journal of Heart Failure, Vol. 13, Núm. 9, pp. 974-983

2007

  1. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials

    Journal of the American Medical Association, Vol. 297, Núm. 12, pp. 1332-1343